The University of Cincinnati has partnered with Eli Lilly to more efficiently determine the importance of research discoveries in areas including Alzheimer's disease, cancer, diabetes and osteoporosis.
The partnership takes university research work and turns it over to Eli Lilly scientists to be examined for further potential. Researchers and the school will retain intellectual property rights, but Lilly will have the first opportunity to partner on further research or enter into a licensing agreement.
Read full article
here.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.